电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

FLT4 Protein (His tag)

This Recombinant FLT4 protein is expressed in HEK-293 Cells.
产品编号 ABIN7195831
发货至: 中国

Quick Overview for FLT4 Protein (His tag) (ABIN7195831)

抗原

See all FLT4 蛋白
FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

蛋白类型

Recombinant

生物活性

Active

宿主

  • 19
  • 4
  • 3
  • 2
小鼠

资源

  • 14
  • 7
  • 3
  • 2
  • 1
  • 1
HEK-293 Cells

纯度

> 97 % as determined by SDS-PAGE
  • 标记

    This FLT4 protein is labelled with His tag.

    原理

    Recombinant Mouse VEGFR3/FLT4 Protein (His Tag)(Active)

    序列

    Met 1-Glu 775

    产品特性

    A DNA sequence encoding the mouse FLT4 (P35917-1) extracellular domain (Met 1-Glu 775) was expressed, with a polyhistidine tag at the C-terminus.

    内毒素水平

    < 1.0 EU per μg of the protein as determined by the LAL method.

    Biological Activity Comment

    1. Measured by its binding ability in a functional ELISA.2. Immobilized mouse VEGFR3-His at 10 μg/mL (100 μl/well) can bind mouse Fc-VEGFD, The EC50 of mouse Fc-VEGFD is 44 ng/mL.
  • 想要此Protein的其他选项吗?

    !
    探索我们的预定义定制蛋白和定制蛋白服务!

    您的项目需要进一步定制吗?联系我们,了解我们的定制蛋白解决方案

  • 限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Please refer to the printed manual for detailed information.

    缓冲液

    Lyophilized from sterile PBS, pH 7.4

    储存条件

    4 °C,-20 °C,-80 °C

    储存方法

    Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
  • 抗原

    FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

    别名

    VEGFR3/FLT4

    背景

    Background: Vascular endothelial growth factor receptor 3 (VEGFR3), also known as FLT-4, together with the other two members VEGFR1 (FLT-1) and VEGFR2 (KDR/Flk-1) are receptors for vascular endothelial growth factors (VEGF) and belong to the class III subfamily of receptor tyrosine kinases (RTKs). The VEGFR3 protein is expressed mainly on lymphatic vessels but it is also up-regulated in tumor angiogenesis. Mutations in VEGFR3 have been identified in patients with primary lymphoedema. The VEGF-C/VEGF-D/VEGFR3 signaling pathway may provide a target for antilymphangiogenic therapy in prostate cancer, breast cancer, gastric cancer, lung cancer, non-small cell lung cancer (NSCLC), and so on.Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

    Synonym: AI323512;Chy;Flt-4;VEGFR-3;VEGFR3

    分子量

    86.4 kDa

    途径

    RTK signaling, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
You are here:
Chat with us!